CARDIFF ONCOLOGY, INC. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
CARDIFF ONCOLOGY, INC. (CRDF) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $4.29 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2026-08-11
- 2026-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $4.29M.
- 2026-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $4.55M.
- 2025-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $4.47M.
- 2025-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $4.40M; Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed $4.32M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed |
|---|---|---|
| 2026-06-30 | $4.29M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $4.55M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $4.47M 10-Q · filed 2026-08-11 | |
| 2025-06-30 | $4.40M 10-Q · filed 2025-11-06 | $4.32M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $4.23M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $4.14M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $4.06M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.95M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.85M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $3.75M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $3.66M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $3.56M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.46M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.41M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $3.33M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $3.48M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $3.47M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.44M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $3.33M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.22M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $3.11M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.00M 10-K · filed 2022-02-24 | $3.00M 10-K · filed 2021-02-25 |
| 2020-09-30 | $2.95M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.84M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $2.72M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.60M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.35M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.31M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.27M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $2.11M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $2.35M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.18M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $2.28M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.07M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $2.53M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.27M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.03M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.76M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $1.54M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.34M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.01M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $854.78K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $732.87K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $644.14K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $559.68K 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $533.87K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $348.60K 10-K · filed 2015-03-12 | |
| 2012-12-31 | $259.64K 10-K · filed 2014-03-17 | |
| 2011-12-31 | $221.80K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |